Conservation of Alternative Polyadenylation Patterns in Mammalian genes. by Ara, Takeshi et al.
Conservation of Alternative Polyadenylation Patterns in
Mammalian genes.
Takeshi Ara, Fabrice Lopez, William Ritchie, Philippe Benech, Daniel
Gautheret
To cite this version:
Takeshi Ara, Fabrice Lopez, William Ritchie, Philippe Benech, Daniel Gautheret. Conserva-
tion of Alternative Polyadenylation Patterns in Mammalian genes.. BMC Genomics, BioMed
Central, 2006, 7, pp.189. <10.1186/1471-2164-7-189>. <inserm-00089585>
HAL Id: inserm-00089585
http://www.hal.inserm.fr/inserm-00089585
Submitted on 22 Aug 2006
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.
BioMed Central
Page 1 of 11
(page number not for citation purposes)
BMC Genomics
Open AccessResearch article
Conservation of alternative polyadenylation patterns in 
mammalian genes
Takeshi Ara1, Fabrice Lopez1, William Ritchie1, Philippe Benech1 and 
Daniel Gautheret*1,2
Address: 1INSERM ERM 206, Université de la Méditerranée, Luminy Case 906, 13288 Marseille, Cedex 09, France and 2Institut de Génétique et 
Microbiologie, Université Paris-Sud – CNRS UMR 8621, Bât 400, 91405 Orsay Cedex, France
Email: Takeshi Ara - ara@tagc.univ-mrs.fr; Fabrice Lopez - lopez@tagc.univ-mrs.fr; William Ritchie - ritchie@tagc.univ-mrs.fr; 
Philippe Benech - benech@tagc.univ-mrs.fr; Daniel Gautheret* - gautheret@esil.univ-mrs.fr
* Corresponding author    
Abstract
Background: Alternative polyadenylation is a widespread mechanism contributing to transcript
diversity in eukaryotes. Over half of mammalian genes are alternatively polyadenylated. Our
understanding of poly(A) site evolution is limited by the lack of a reliable identification of conserved,
equivalent poly(A) sites among species. We introduce here a working definition of conserved
poly(A) sites as sites that are both (i) properly aligned in human and mouse orthologous 3'
untranslated regions (UTRs) and (ii) supported by EST or cDNA data in both species.
Results: We identified about 4800 such conserved poly(A) sites covering one third of the
orthologous gene set studied. Characteristics of conserved poly(A) sites such as processing
efficiency and tissue-specificity were analyzed. Conserved sites show a higher processing efficiency
but no difference in tissular distribution when compared to non-conserved sites. In general,
alternative poly(A) sites are species-specific and involve minor, non-conserved sites that are
unlikely to play essential roles. However, there are about 500 genes with conserved tandem
poly(A) sites. A significant fraction of these conserved tandems display a conserved arrangement
of major/minor sites in their 3' UTR, suggesting that these alternative 3' ends may be under
selection.
Conclusion: This analysis allows us to identify potential functional alternative poly(A) sites and
provides clues on the selective mechanisms at play in the appearance of multiple poly(A) sites and
their maintenance in the 3' UTRs of genes.
Background
Alternative polyadenylation site selection is an important
source of transcript diversity in higher eukaryotes. The
resulting 3' untranslated region (UTR) variants may differ
by their cellular localization, stability or translational effi-
ciency, thus contributing to tissue-specific or develop-
mental stage-specific regulation of gene function [1]. For
at least 50% of genes in mammalian genomes, several
polyadenylation sites are present and mRNAs with differ-
ent 3'UTR regions can be produced from a single gene [2-
4]. Alternative poly(A) sites are commonly classified into
tandem poly(A) sites that locate in the same 3'-exon, and
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sites located in different exons (including composite
exon) formed by alternative splicing [1,4,5]. Alternative 3'
ends involving different 3' exons may impact the coding
sequence and therefore have obvious functional conse-
quences. However, the actual functional impact of tan-
dem poly(A) sites, producing 3' ends that differ solely by
the length of the 3' UTR, is still largely unknown.
Analysis of tissular biases in poly(A) site usage has sug-
gested a frequent tissue-specific regulation of 3' variants in
human [6-8]. Recent studies have re-examined alternative
polyadenylation in the light of comparative genomics [3-
5,7-9]. Features such as the presence of multiple cleavage
sites, distribution of poly(A) signal variants and nucle-
otide composition of flanking regions were reported to be
similar in human and mouse [4]. In addition, the num-
bers and organization of polyadenylation sites in human
and mouse orthologs showed significant correlations,
suggesting that some alternative polyadenylation patterns
are evolutionarily conserved. These studies, however, did
not directly address the conservation and functional sig-
nificance of individual poly(A) sites. Here, we further
exploit the tools of comparative genomics to identify and
characterize functional alternative polyadenylation sites
in the human and mouse genome.
In order to study the evolutionary conservation of poly(A)
sites, we need to reliably identify homologs of each alter-
native poly(A) site in a given gene. We introduce here a
method to perform this assignment using both multiple
alignments of 3'UTR regions and EST mapping of polya-
denylation sites. The functional analysis of conserved and
non-conserved poly(A) sites was then carried out based
on EST counts and cDNA/EST library information. This
resulted in the identification of about 4800 poly(A) sites
conserved between human and mouse genes. Comparing
the processing efficiency, tissue-specificity and spatial
location of conserved and non-conserved poly(A) sites,
we identified the characteristic features of conserved sites
and estimated the ratio of alternative poly(A) sites under
selective pressure. This analysis was complemented by a
listing of conserved poly(A) sites with possible tissue-spe-
cific usage.
Results
Identifying conserved and non-conserved poly(A) sites
We performed a complete mapping of all 3' ESTs and full-
length cDNAs onto the human and mouse genomes. After
clustering EST and cDNA hits, potential poly(A) sites were
identified based on several quality criteria including the
presence of at least two ESTs/cDNA ending at site, reduced
dangling ends in Blast matches, lack of potential internal
priming tract in downstream genomic region and pres-
ence of a canonical or variant poly(A) signal near 3' end.
We identified a total of 66,647 and 52,270 candidate
poly(A) sites in the human and mouse genome, respec-
tively which were then mapped to flanking Ensembl-
annotated genes.
Alternative poly(A) site may be found in tandem in the
same 3' exon, or in different 3' exons when associated to
alternative splicing. We want to avoid the latter case, as
poly(A) site usage may be dictated first by alternative
splicing, which is itself conserved to some extent for spe-
cific genes in animal genomes [10,11]. To avoid interfer-
ence from alternative splicing, we only considered
poly(A) sites located in the 3'-most exon, and following
the 3'-most stop codon in case of alternative splice forms.
This retained 27,654 poly(A) sites for 14,574 human
genes and 25,987 poly(A) sites for 15,199 mouse genes.
The resulting estimate of 1.8 poly(A) sites/gene is compa-
rable to previous ones [4,5] with a slight increase for
mouse imputable to an expanded mouse EST database.
To compare poly(A) sites located on ortholog gene pairs
in human and mouse, we aligned 3'UTR regions of all
14,481 ortholog pairs and we defined as "conserved"
those human and mouse poly(A) sites displaying aligned
poly(A) signals and EST/cDNA support in both species
(Figure 1A). Poly(A) sites with EST/cDNA support whose
poly(A) signals were not aligned were considered as non-
conserved (Figure 1B), even when the cleavage site itself
was properly aligned (Figure 1C). Multiple aggregated
cleavage sites occurring after a single poly(A) signal (only
~1% of total poly(A) sites in our procedure) were dis-
carded. We obtained a total of 4,807 conserved poly(A)
sites and 33,458 non-conserved poly(A) sites. The con-
served/non-conserved ratio is about 0.3 in either species.
Among conserved poly(A) sites, 3711 were single sites
and 1096 were multiple sites from 503 orthologous gene
pairs. By our definition, 20% of human genes have a con-
served poly(A) site and 2.5% of human genes have multi-
ple conserved poly(A) sites. Figure 2 shows that
conservation is higher in single poly(A) sites (33%) than
in tandem poly(A) site (18%). This suggests that alterna-
tive poly(A) sites are evolutionally less conserved than
single poly(A) sites. The complete list of human/mouse
conserved poly(A) sites is presented in Additional file 1.
Number of sites and position in UTR
Tian et al. [4] have reported that poly(A) site configura-
tions (single sites, tandem sites or sites located in different
exons) tend to be conserved between human and mouse.
The conservation of the number of tandem poly(A) sites
in homologous gene, however, was not assessed. Figure 3
shows the distribution of poly(A) site numbers in human
and mouse orthologous pairs, for genes having one or
more sites, conserved or non-conserved. Numbers of
poly(A) sites are significantly correlated in orthologs (P =
6.2 × 10-260, χ2 test). In other words, a human gene with
BMC Genomics 2006, 7:189 http://www.biomedcentral.com/1471-2164/7/189
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multiple poly(A) sites tends to have multiple poly(A) sites
in mouse too, suggesting that a selective mechanism acts
on the number of alternative polyadenylation sites.
Do conserved tandem poly(A) sites show any positional
preference in the 3'UTR region? We examined all tandem
poly(A) sites, and classified them as "proximal" or "distal"
according to their position relative to the stop codon. For
genes with an odd number of sites, the site located in the
central position was excluded (10% of sites overall). Fig-
ure 4 shows relative locations of conserved and non-con-
served tandem poly(A) sites. In both human and mouse,
conserved sites tend to occur more often in the proximal
part of the UTR, while non-conserved sites tend to occur
more often in the distal part.
Distribution of ortholog gene pairs against polyadenylation site numbers in human and mouse genesFigure 3
Distribution of ortholog gene pairs against polyadenylation 
site numbers in human and mouse genes. Table cells provide 
numbers of orthologous gene pairs in function of the number 
of polyadenylation sites in human genes (rows) and in mouse 
genes (columns). Expected values, based on the null hypothe-
sis that there is no correlation, are shown in parentheses. 
Correlation P value: 6.2 × 10-260 (χ2 test).
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Definition of conserved and non-conserved polyadenylation sitesFigure 1
Definition of conserved and non-conserved polyadenylation 
sites. Cleavage sites are shown by flags and polyadenylation 
signals are shown by black squares. (A) sites are within 30 bp 
of each other and aligned associated signals: conserved; (B) 
sites are within 30 bp of each other, however, their associ-
ated signals are not aligned: non conserved; (C) although the 
sites themselves are aligned, their signals are not: non con-
served.
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Processing efficiency
We estimated the relative processing efficiency (RE) of
poly(A) sites based on EST counts, normalized in such a
way that the highest EST count of all poly(A) sites from
the same gene had a value of one. This eliminates biases
resulting from different EST coverage in different genes
and between human and mouse (see Methods). Figure 5A
compares the human/mouse correlation coefficients of RE
in conserved poly(A) sites (r = 0.45, arrow) and in 10,000
sets of randomly selected non-conserved sites from
orthologous genes (histogram). The relative efficiency of
conserved poly(A) site is correlated between human and
mouse, while that of non-conserved sites from ortholo-
gous genes is not.
Figure 5B shows the distribution of relative efficiencies in
conserved and non-conserved poly(A) sites. If one consid-
ers as "major" any site with RE above 0.5, then conserved
sites are more often of the major type (85%) than non-
conserved sites (75%). This observation raises a question
about the nature of conserved sites. Is the higher process-
ing efficiency of conserved sites associated to some selec-
tive constraint, or to the presence of non-functional and/
or misprediction among non-conserved sites? To answer
this question, we subdivided non-conserved mouse sites
according to their conservation or lack thereof in rat
orthologous genes (Figure 6). Poly(A) sites conserved
between mouse and rat behave in the same fashion as
poly(A) sites conserved between mouse and human, i.e.
with a predominance of "major" sites. This suggests that
the higher efficiency of conserved human/mouse sites is
due firstly to their status of biologically functional sites,
rather than to a property of ancient conserved sites.
Tissue specificity
We then analyzed the tissue specificity of poly(A) sites
based on the eVOC expression ontology system [12]. Ver-
sion 2.6 of eVOC maps each of the 9,478 human EST
libraries to a formalized tissue description. As a mouse
version of eVOC was not available at the time of the study,
we further mapped 556 mouse EST libraries using the
same formal description system (See Materials and Meth-
ods). We obtained for each poly(A) site the number of dif-
ferent tissues in which the site is observed, among the 12
possible top-level eVOC tissue categories. Since tissue
counts are highly dependent on EST coverage, we normal-
ized tissue counts versus an expected number of tissues
Relative efficiency of conserved and non-conserved polyade-nylation sitesFigure 5
Relative efficiency of conserved and non-conserved polyade-
nylation sites. (A) Distribution of 10,000 control correlation 
coefficients each computed from 1000 random pairs of non-
conserved sites from orthologous human and mouse genes. 
Arrow indicates the correlation coefficient observed for 
pairs of conserved sites (r = 0.45). (B) Distribution of relative 
efficiency of conserved and non-conserved polyadenylation 
sites. Number of sites in human (white) and mouse (black) is 
plotted against relative efficiency.
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obtained from a random EST sample of same size. Our
measure of tissue specificity is the log ratio of observed vs.
expected number of tissues. About 10% of tandem
poly(A) sites have a tissue specificity below -0.5 (high spe-
cificity) and <3% above 0.5 (low specificity). Non-con-
served poly(A) sites showed no correlation in tissue
specificity (Fig 7A, histogram), while conserved sites had
weakly correlated tissue specificities (r = 0.10, Fig 7A,
arrow). This observed difference is not significant based
on a T-test performed after Fisher's z-transformation of
the r value (P < 0.5).
To circumvent possible gene-level expression biases, we
measured a "relative tissue specificity" (RTS), by assigning
a value of 1 to the poly(A) site with the broadest tissue dis-
tribution in a gene. Each gene thus has at least one site
with RTS = 1. The distribution of other sites is shown in
Figure 7B. Interestingly, very few sites have a RTS below
0.5. The fact that most sites have a RTS close to 1, that is
close to the broadest possible tissue distribution for this
gene, means variations in tissue specificity between suc-
cessive poly(A) sites in a gene are generally limited. We
used the median RTS to distinguish "broad" from "nar-
row" sites (we preferred these terms over "constitutive"
and "specific" since these would suggest an absolute usage
level, while here we only measure relative usage). Sites
with an RTS above median (0.90 for human, 0.88 for
mouse) are said to display a "broad" tissue distribution
while other sites are said to display a "narrow" tissue dis-
tribution. Based on this definition, broad and narrow tis-
sue distributions are equally frequent among conserved
and non-conserved sites (Figure 7B). Broad and narrow
tissue distributions are also equally distributed among
major and minor sites (Additional file 2).
Spatial preferences vs. efficiency or specificity
We examined the relationship between the spatial organ-
ization of tandem poly(A) sites and site efficiency or spe-
cificity. Poly(A) sites were classified as major/minor or
Relative tissue-specificity of conserved and non-conserved po yad nylation sitesFigure 7
Relative tissue-specificity of conserved and non-conserved 
polyadenylation sites. (A) Distribution of 10,000 control cor-
relation coefficients each computed from 1000 random pairs 
of non-conserved sites from orthologous human and mouse 
genes. Arrow indicates the correlation coefficient observed 
for pairs of conserved sites (r = 0.10). (B) Distribution of rel-
ative tissue-specificities in conserved and non-conserved 
polyadenylation sites. Number of sites in human (white) and 
mouse (black) is plotted against relative tissue specificity.
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narrow/broad as described above, and their spatial organ-
ization was observed in genes containing two or more tan-
dem conserved sites. A "conserved usage pattern" was
recorded when successive tandem sites had the same effi-
ciency and/or specificity pattern in human and mouse
orthologs (Figure 8A). We observed that 53% of genes
with tandem conserved poly(A) sites had a conserved effi-
ciency pattern (227 gene pairs), significantly higher than
expected by chance (146 gene pairs, binomial distribution
P = 9.7 × 10-28). Comparing expected and observed values,
81 genes would have a poly(A) site efficiency pattern
under selection. This tendency is not observed for tissue
specificity: 133 gene pairs have a conserved tissue specifi-
city pattern vs. 141 expected by chance.
In Figure 8B, we focus on genes containing at least one
conserved major site, as a surrogate for sites existing prior
to human-mouse divergence. We then observe how such
sites are associated to flanking conserved (black) or non-
conserved (gray) sites, using flanking non-conserved sites
as surrogates for emerging sites. Interestingly, while
emerging minor sites are as frequent on the 5' or 3' side of
existing major sites (top row), pairs of conserved sites
(bottom row) are twice more often 5'minor/3'-major than
5'-major/3'-minor. This suggests that selection of alterna-
tive poly(A) sites favors the pattern 5'-minor/3'-major
over the pattern 5'-major/3'-minor.
Differentially processed Poly(A) sites
We define here as differentially processed those alterna-
tive poly(A) sites with a significantly biased usage in any
tissue class, as compared with other poly(A) sites from the
same gene. Differential usage was measured using a Fisher
test as previously reported [6]. Using a Bonferroni correc-
tion for multiple testing, five conserved and 84 non-con-
served sites are differentially processed in human (54 and
369, respectively, in mouse).
We examined the relationship between differential
processing and site efficiency or tissue specificity. Consist-
ently with a recent study of tissue-specific polyadenyla-
tion [8], minor sites are more often differentially
processed than major sites (Figure 9A). Although this
study did not identify tissue biases in major sites, we do
observe a few occurrences (9 in human, 64 in mouse) of
major sites with differential processing. Differential
processing is also much more frequent in non-conserved
than in conserved sites (Figure 9B).
Expectedly, there is a high correlation between differential
usage and the "narrow" or "broad" status of a site. Differ-
entially processed sites are about three times more often
of the narrow type than of the broad type (data not
shown). Although counterintuitive, some poly(A) sites
can be at the same time differentially processed and of
broader usage, because our specificity measure is relative
and always classifies as broad the site with the broadest
tissue usage, even when usage is restricted to a single tis-
sue.
A list of differentially processed, conserved poly(A) sites is
presented in Additional file 3. Differentially processed
sites are observed in all tissue classes (Figure 10). The
apparent overrepresentation of urogenital and nervous
systems is not significant when EST library coverage is
taken into account. EST coverage is not sufficient either to
provide interspecies confirmation of tissue biases. No
Spatial efficiency/specificity patterns and conservationFigure 8
Spatial efficiency/specificity patterns and conservation. (A) 
Definition of spatial efficiency/specificity patterns. Ortholog 
gene pairs with identical numbers of conserved polyadenyla-
tion sites are considered. A conserved pattern is defined as a 
series of sites between two orthologous genes, where each 
site bares the same properties (major/minor or broad/nar-
row) as its orthologous counterpart (e.g. gene X). All other 
patterns are defined as non-conserved (e.g. gene Y). (B) Rela-
tionship between tandem poly(A) site spatial patterns and 
conservation. The first row shows different patterns in which 
one major site is conserved. The second row shows different 
patterns in which two sites are conserved. Numbers of 
human genes ("h") and mouse genes ("m") displaying each 
pattern are shown. Circled numbers indicate ratio of pat-
terns in second row over patterns in first row.
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conserved site is found differentially processed in both
human and mouse after Bonferroni correction.
Conserved sequence motifs around conserved sites
As our criteria for poly(A) site conservation imply a cor-
rect alignment of poly(A) signals, we suspected that con-
served sequences around poly(A) signals could also
contribute to poly(A) site conservation. This region is
known to contain elements such as the USE (upstream
sequence element) and DSE (downstream sequence ele-
ment), two U-rich elements involved in the control of
poly(A) site efficiency [13-15], as well as a number of
potential regulatory motifs of unknown function [7]. A
possible explanation for proper signal alignment and
increased cleavage efficiency at conserved poly(A) sites
could be related to the occurrence of such control ele-
ments in both human and mouse orthologs. Although
downstream regions appear slightly more U-rich in con-
served sites than in non-conserved sites (see Additional
file 4), indicative of stronger DSE elements [15], we could
not find overrepresented sequence motifs occurring in
more than a few conserved sites. Therefore, there is no
widespread cis-regulatory element that would explain
poly(A) site conservation.
Discussion
We introduced here a definition of conserved poly(A)
sites as sites supported by 3' ESTs or full length cDNAs in
ortholog gene pairs and located downstream of a properly
aligned AAUAAA or variant signal in the pairwise 3' UTR
alignment. Applying this rule to human and mouse
orthologs, we observed 4,807 conserved poly(A) sites, i.e.
about 22% of the human sites tested. Only a third of the
human/mouse orthologous gene pairs contains one or
more conserved sites by this definition.
Gene Ontology (GO) term analysis suggests links between
alternative polyadenylation and specific functions. As pre-
viously reported [4], genes with tandem poly(A) sites are
enriched in terms "intracellular" (cellular component;
GO:0005622) and "protein transport" (biological proc-
ess; GO:0015031). Now, if all tandem sites are used as a
reference, genes with conserved tandem sites are further
enriched for terms "nucleus" (cellular component;
GO:0005634, number of gene n = 129, P = 5.5 × 10-5 for
human and n = 125, P = 1.0 × 10-7 for mouse) and "ubiq-
uitin cycle" (biological process; GO:0006512, n = 27, P =
6.2 × 10-6 for human and n = 23, P = 8.4 × 10-5 for mouse).
The nucleus encompasses evolutionally conserved DNA
and RNA processing machineries. Alternative polyade-
nylation may be more conserved in genes within such cel-
lular systems. The ubiquitin cycle is also well conserved
among eukaryotic genomes and involves genes contain-
ing highly conserved 3' UTR elements in vertebrates [16].
This is consistent with posttranscriptional regulations
Tissue-distribution of differentially-processed, polyadenyla-tion sites, in human (whit ) and mouse (black)F g re 10
Tissue-distribution of differentially-processed, polyadenyla-
tion sites, in human (white) and mouse (black).
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Distribution of differentially-processed polyadenylation sitesFigure 9
Distribution of differentially-processed polyadenylation sites. 
(A) Ratio of differentially-processed sites (P < 0.05, Fisher's 
exact test with Bonferroni correction) against total sites, for 
human (white) and mouse (black) genes, shown for major 
and minor sites. (B) Ratio of differentially-processed sites (P 
< 0.05, Fisher's exact test with Bonferroni correction) 
against total sites, shown for conserved and non-conserved 
sites. Value above each bar show absolute numbers of differ-
entially-processed sites.
P
e
rc
e
n
ta
g
e
 o
f 
d
if
fe
re
n
ti
a
lly
 
A B
p
ro
c
e
s
s
e
d
 s
it
e
s
 (
%
)
6 4
0
2
cons. non-
cons.
0
3
major minor
human
mouse
64
9
359
80
5
56
84
369
BMC Genomics 2006, 7:189 http://www.biomedcentral.com/1471-2164/7/189
Page 8 of 11
(page number not for citation purposes)
involving this region and hence with a selective pressure
for conserved tandem poly(A) sites.
Among genes with tandem poly(A) sites (70% of our
mapped gene set), the most frequent patterns involve
either only non-conserved sites (~3000 genes) or a single
conserved site flanked by non-conserved sites (~2000
genes). There are only about 500 genes with two or more
conserved poly(A) sites. When comparing the efficiency
and specificity of poly(A) sites in a tandem configuration,
a general picture emerges where conserved sites generally
show a higher efficiency and fewer instances of differen-
tial processing than non-conserved sites. The majority of
minor or tissue-specific sites are non-conserved, suggest-
ing that alternative polyadenylation is most frequently a
species-specific event. This is reminiscent of what was
observed for alternative splicing. Modrek et al. [10]
reported that, for skipped exons, major forms are more
often conserved than minor forms, thus suggesting that
alternative splicing is more often species-specific as well.
We found that processing efficiency was significantly cor-
related between human and mouse at conserved sites.
Again, this pattern is reminiscent of that observed for
alternative splicing. Looking at conserved alternative
splicing events, Kan et al. observed strong correlations of
human/mouse expression levels that were suggestive of
functional alternative splicing events [11].
We observed that the spatial organization of major/minor
poly(A) sites in a gene is conserved more often than
expected by chance. This suggests that, for some genes,
specific usage patterns of alternative poly(A) sites were
established prior to the human/mouse divergence and
were maintained by selection. We estimate this should
concern no more than one hundred genes.
The large number of non-conserved poly(A) sites, espe-
cially among tandem sites, suggests that gain/loss of alter-
native poly(A) sites is a frequent event in mammalian
genomes. New poly(A) signals may arise from duplica-
tions, insertion events or point mutations. The latter is
probably a more parsimonious hypothesis when consid-
ering the AU-rich nature of non-coding human sequences
and the presence in UTRs of AU-rich elements such as the
AREs, resembling poly(A) signals. However, new signal
arising from point mutation are most likely deprived from
enhancing elements and hence should produce transcript
isoforms in very small quantities, especially if located
downstream of a strong site. On the other hand, poly(A)
sites resulting from duplication or insertion of a func-
tional signal and its associated enhancing elements
maybe readily functional and able to compete effectively
with alternative sites.
Are new alternative sites selectively neutral and what is
their fate? Novel 3' variants can be non-neutral for
instance when containing regulatory motifs such as
miRNA targets or destabilization elements, or when
affecting translation efficiency through the sheer effect of
3' UTR size [17]. Our observation that tandem poly(A)
sites are generally less conserved than unique sites sug-
gests that most novel sites are quickly lost and therefore
are either neutral or deleterious. Interestingly, spatial pat-
terns of the type 5'-major/3'-minor are underrepresented
in conserved tandem sites (Figure 8B). This is consistent
with a model where novel poly(A) sites arising 3' to exist-
ing sites tend to be lost more quickly, unless stronger than
existing 5' sites. Through the accidental occurrence and
loss of novel poly(A) sites in the 3' UTR, natural selection
would thus tend towards a topology involving a minor
short isoform and a major long isoform, which is indeed
the most frequent topology observed for polyadenylation
isoforms [2].
Conclusion
We used comparative genomics to identify and character-
ize functional polyadenylation sites in the human and
mouse genomes. A genome-wide computational analysis
of alternative polyadenylation sites allowed us to identify
about 4800 conserved poly(A) sites. Conserved sites dis-
play a higher processing efficiency than non-conserved
sites, but display no difference in tissue distribution. We
focused on tandems of conserved sites and sought biases
in site usage and position in UTR. The 5'/3' order of major
and minor sites in conserved tandems is more conserved
than expected by chance, suggesting that selective pressure
acts on poly(A) site usage and therefore that resulting
alternative transcripts may have functional significance.
Some unanticipated patterns deserve further scrutiny,
such as major sites with a predicted differential usage, or
conserved sites that yet are of the minor or tissue-specific
type. Transcripts displaying such unexpected poly(A) site
usage patterns could be prioritized for experimental vali-
dation.
Methods
Poly(A) site prediction
EST sequences were obtained from dbEST v. 01/06/05
(6,009,051 human, 4,314,509 mouse and 623,741 rat
ESTs). Full-length cDNA sequences were obtained from
H-Inv 1.8 (41,118 sequences) [18] and FANTOM 2.01
(60,770 sequences) [19]. ESTs annotated as 3' were
extracted (2,029,534 human, 1,864,874 mouse and
293,597 rat ESTs) and trailing poly(A) or poly(T)
sequences of 5 nt or more were removed, with one mis-
match (non-A or non-T) allowed for polyA/T tails of 10 or
more. Both 3' EST and cDNA sequences were aligned to
the repeat-masked human genome v27.35a.1, mouse
genome v27.33c.1 and rat genome v27.3e.1 using the
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Megablast program [20]. We did not use a specific exon
junction mapping software, since we were only interested
in the terminal part of the 3' exon. All hits presenting at
least 95% identity with the genomic sequence were
retained (hit size >28 nt at default E-value). Partial hits
flanking a repeat masked region of the genome were then
realigned to the locally unmasked region. Hits with 95%
identity after this step were retained. Clusters were formed
with ESTs having either their 5' or 3' extremities falling
within a 10 nt distance. ESTs were not oriented at this
stage. Each cluster was analyzed using a sliding window to
locate the most likely cleavage site, defined as the position
where the window contains the most EST/cDNA ends. The
following filters where then applied:
(i) Dangling ends: discard hits with more than 5
unmatched nt at cleavage site
(ii) Internal priming: discard cleavage sites flanked by A-
rich region (at least 9 As out of 10 nt) in the 50 nt down-
stream genomic sequence
(iii) Poly(A) signal: retain only cleavage sites where 30 nt
upstream genomic sequence contains one of the 11 vari-
ant poly(A) signal identified in our previous study [2]:
AATAAA, ATTAAA, AGTAAA, TATAAA, CATAAA, GATAAA,
AATATA, AATACA, AATAGA, AATGAA, ACTAAA
Only those cleavage sites passing the filters and supported
by at least two ESTs/cDNAs were retained as predicted
poly(A) sites. From the starting EST/cDNA datasets we
finally retained 718,927 ESTs and 19,626 full length
cDNAs to identify 66,647 different poly(A) sites in
human, 739,259 ESTs and 23,069 full length cDNAs to
identify 52,232 different poly(A) sites in mouse and
119,946 ESTs to identify 27,494 different poly(A) sites in
rat.
Assignment of tandem Poly(A) signal sites
Poly(A) sites were assigned to transcript sequences taken
from Ensembl 27.35a.1 [21]. If the poly(A) site lied
within one or more annotated transcripts, downstream of
the end of translation, the site was affected to each of these
transcripts. If the poly(A) site lied upstream of the end of
translation, then it was considered as "in CDS" and is not
used for analysis. If the poly(A) site did not map to any
annotated transcript, it was affected to the nearest 5' tran-
script. Poly(A) signals were assigned to their respective
poly(A) sites by taking the signal that was closest to the 5'-
most poly(A) site in each cluster. Only poly(A) sites map-
ping to the 3'-most exon of an Ensembl gene or its
genomic downstream region up to 10 kb were considered
further.
Assignment of conserved Poly(A) sites
Ortholog human/mouse (or mouse/rat) gene pairs were
obtained from EnsMart [22]. All genes with paralogs were
omitted from the analysis. 3'UTR regions assigned in
Ensembl including up to 10 kb downstream genomic
sequence of all transcripts were aligned by ClustalW with
default parameter. Predicted Poly(A) sites were then
defined as conserved if they were within a distance of 30
bp of a properly aligned poly(A) signal and had EST-sup-
port in both human and mouse. In the case where multi-
ple poly(A) signals were associated to a single cleavage
site, the signal closest to the cleavage site was used for the
analysis. Multiple cleavage sites that were associated to the
same poly(A) signal were omitted.
Mouse eVOC ontology mapping
Anatomical terms in mouse cDNA libraries were mapped
to anatomical systems from the eVOC ontology ver 2.6
[12]. Terms that matched exactly to human eVOC terms
were kept and all mixed terms (e.g. lung and colon) were
manually checked to see if each component could match
to a human eVOC term. Any terms that could not be
directly mapped were classified as "unclassifiable". Finally
all libraries were assigned to 12 anatomical systems: ana-
tomical site, cardiovascular, respiratory, hematological,
lymphoreticular, alimentary, urogenital, endocrine, mus-
culoskeletal, dermal, nervous and unclassifiable.
Correlation analysis
χ2 test, t-test, calculation of correlation coefficient and
Fisher's z-transformation were performed using Microsoft
Excel 2002. Distributions of observed and random dis-
tributed values were calculated using dedicated Perl
scripts.
Efficiency and tissue specificity
All EST counts were performed after discarding EST librar-
ies annotated as normalized in the dbEST database (3% of
overall human and mouse libraries). The relative effi-
ciency R of a poly(A) site was calculated as a ratio of
number of ESTs,
where nx,i is the number of ESTs of poly(A) site i within
gene X, and nX,max is maximum number of ESTs of any tan-
dem poly(A) site within gene X.
Sites with a ratio higher than 0.5 were defined as "major"
(high efficiency), while other sites were defined as
"minor" (low efficiency).
The specificity of a poly(A) site was defined as the number
of different expression systems in which this site was uti-
R
n
n
i
X i
X
=
,
,max
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lized, normalized by the number of supporting ESTs as
follows. For a poly(A) site supported by N ESTs, we calcu-
lated an expected number of expression systems as the
average number of expression systems obtained in 10,000
random sets of N ESTs sampled from the complete set of
ESTs mapping any poly(A) site. Specificity S was then cal-
culated as the log-ratio of the number of expression sys-
tems:
where T is observed number of different expression sys-
tem in each poly(A) site, Tsim [n] is the simulated number
of different expression systems for n ESTs.
For genes with tandem poly(A) sites, a relative tissue spe-
cificity U was calculated for each site, as the ratio of tissue
specificities:
where SX,i is tissue specificity of each tandem poly(A) site
i within gene X, SX,max is maximum tissue specificity of tan-
dem poly(A) site within gene X, and Smin is minimum
value of S in each species. We adjusted the interval of rel-
ative tissue specificity to 0–1; 0 being the most specific site
and 1 being the least specific. Median ratio was 0.90 for
human, 0.88 for mouse. Sites with a ratio higher than
these values were defined as "broad" while others were
defined as "narrow".
A usage pattern was defined as the sequence of relative
efficiencies or relative tissue specificities for all tandem
poly(A) sites in a gene. For each usage pattern, the
expected value E of the number of gene pairs that could
randomly bare this pattern was calculated from a random
combination of human and mouse gene pairs with con-
served tandem poly(A) sites as described below. For a
number of conserved poly(A) sites j, the list of relative
usage patterns L [j, k] was defined by
L [j, k] = {[r1, r2,...,rj]1, [r1, r2,...,rj]2, ..., [r1, r2,..., rj]k}
where rj = {major or minor} or {broad or narrow}. For a
number N of genes and the number of conserved poly(A)
sites j, a probability P for human and mouse poly(A) sites
having pattern L [j, k] was defined as:
Then the expected value E for the maximal value of k (kmax
= 2j-1) is :
Expected frequencies of genes with narrow usage patterns,
based on a binomial distribution, were calculated by
Microsoft Excel 2002.
Differential use of poly(A) sites
To identify differentially processed poly(A) sites, Fisher's
tests were performed on the distribution of the number of
supporting ESTs from each expression system against all
other systems for each poly(A) site as previously described
[6]. A Bonferroni correction for multiple testing was
applied. Poly(A) sites supported only by ESTs from
pooled tissue libraries were omitted.
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